Pharmaceuticals
Charles River Labs Is Still Facing a Downward Current
Here's what the stock needs to do on the charts before heading upstream.
Regeneron Stock Is Attempting an Upside Breakout
Let's check to see if these gains by the biotech can be sustained.
As Biogen Surges on Alzheimer Trial Results, Here's How to Play It
BIIB shares have jumped around 50% in early trading activity Wednesday.
I'm Taking the Conservative Route With My Money
It's time to play defensive as nearly all the economic signs point to a slowing economy, which won't be good for stocks.
This Infection-Fighting Biotech Is Recovering Nicely
After a deal with GlaxoSmithKline, the small-cap antibiotic developer Spero Therapeutics should get a shot as an options play.
Point of No Return, Punishing Mistakes, Gnarly Bond Spread, 2 Possible Catalysts
Plus, we take looks at Eli Lilly and Raytheon Technologies after positive news developments for both companies.
GoodRx Stock Looks Ready to Be Priced Like a Generic Drug
The charts don't look promising for GDRX.
Should Investors Buy a Pullback in Gilead Sciences?
The charts give us an answer.
Here's My Prescription for Bristol-Myers Squibb
I'm bullish long term, but for now, can BMY generate follow-through buying?
Bad News Beset This Biotech, but I See a Boost Ahead
TG Therapeutics could see a win with its multiple sclerosis therapy -- and I've got a lesson for traders staying nimble.